Clinical Trial Update: Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and tolerability of subcutaneously administered treprostinil sodium in patients with severe non-operable chronic thromboembolic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-operable Chronic Thromboembolic Pulmonary Hypertension
• Thromboembolic Pulmonary Hypertension

Drugs mentioned

• treprostinil sodium (treprostinil sodium)

Snippet

Sponsor: SciPharm SàRL | Conditions: Non-operable Chronic Thromboembolic Pulmonary Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2019-06-10